NuCana (NCNA) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Silo Pharma is the larger company by market cap ($3.7 million vs $3.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NCNA | SILO |
|---|---|---|
| Share price | $0.7495 | $1.71 |
| Market cap | $3.61M | $3.69M |
| 1-day change | +4.39% | -9.04% |
| EPS (TTM) | $0.00 | $-2.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $72.10K |
| Revenue growth (YoY) | — | 0.00% |
| Net income (latest FY) | — | $-4.23M |
| Gross margin | — | 38.57% |
| Operating margin | — | -5936.95% |
| Net margin | — | -5863.50% |
| 52-week high | $4.55 | $10.43 |
| 52-week low | $0.62 | $1.10 |
| Distance from 52-week high | -83.53% | -83.60% |
| Average volume | 118.13K | 65.47K |
| Shares outstanding | 4.82M | 2.16M |
| Employees | 10 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About NuCana
NCNA stock →NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
NCNA vs SILO FAQ
Which is bigger, NuCana or Silo Pharma?
Silo Pharma (SILO) is larger, with a market capitalization of $3.69M compared with $3.61M for NuCana (NCNA).
Are NuCana and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.